BI
OLMA icon

BVF Inc’s Olema Pharmaceuticals OLMA Stock Holding History

BVF Inc’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$79M Hold
5,295,893
– – 2.52% 15
2025
Q4 		$132M Hold
5,295,893
– – 4.46% 5
2025
Q3 		$51.8M Hold
5,295,893
– – 2.1% 18
2025
Q2 		$22.6M Hold
5,295,893
– – 0.81% 22
2025
Q1 		$19.9M Sell
5,295,893
-420,000
-7% -$2.11M 0.81% 24
2024
Q4 		$33.3M Sell
5,715,893
-3,420,000
-37% -$34.2M 1.13% 22
2024
Q3 		$109M Hold
9,135,893
– – 3.19% 6
2024
Q2 		$98.9M Hold
9,135,893
– – 2.77% 9
2024
Q1 		$103M Hold
9,135,893
– – 2.84% 10
2023
Q4 		$128M Hold
9,135,893
– – 3.21% 7
2023
Q3 		$113M Buy
9,135,893
+1,524,390
+20% +$15.5M 3.04% 6
2023
Q2 		$68.7M Hold
7,611,503
– – 1.92% 16
2023
Q1 		$26.4M Hold
7,611,503
– – 0.97% 33
2022
Q4 		$18.6M Hold
7,611,503
– – 0.79% 41
2022
Q3 		$21M Hold
7,611,503
– – 0.87% 38
2022
Q2 		$31M Buy
7,611,503
+200,000
+3% +$634K 1.5% 24
2022
Q1 		$31.6M Hold
7,411,503
– – 1.26% 24
2021
Q4 		$69.4M Buy
7,411,503
+750,000
+11% +$15.5M 2.52% 13
2021
Q3 		$184M Hold
6,661,503
– – 7.16% 3
2021
Q2 		$186M Hold
6,661,503
– – 6.99% 3
2021
Q1 		$221M Hold
6,661,503
– – 8.29% 2
2020
Q4 		$320M Buy
+6,661,503
New +$312M 12.6% 1

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BVF Inc's OLMA Position: Q1 2026 in Review

BVF Inc held its Olema Pharmaceuticals (OLMA) position steady in Q1 2026 at 5,295,893 shares worth $79M. The position accounts for 2.52% of the portfolio, ranked #15.

BVF Inc first reported a position in OLMA in Q4 2020 and has held it in 22 quarters since. The position peaked at $320M in Q4 2020. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • BVF Inc held 5,295,893 shares of Olema Pharmaceuticals worth $79M as of Q1 2026.
  • BVF Inc left its Olema Pharmaceuticals share count unchanged in Q1 2026.
  • Olema Pharmaceuticals made up 2.52% of BVF Inc's portfolio in Q1 2026, its #15 holding.
  • BVF Inc first reported a position in Olema Pharmaceuticals in Q4 2020 and has held it in 22 quarters since.
  • BVF Inc's Olema Pharmaceuticals position peaked at $320M in Q4 2020.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on BVF Inc's 13F filing for Q1 2026, filed 15 May 2026.